Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome.
Cho BS, Kim YJ, Cho SG, Kim SY, Eom KS, Kim HJ, Lee S, Min CK, Kim DW, Lee JW, Min WS, Kim CC. Cho BS, et al. Among authors: min ws, min ck. Int J Hematol. 2007 Jun;85(5):446-55. doi: 10.1532/IJH97.A30616. Int J Hematol. 2007. PMID: 17562624 Clinical Trial.
The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ, Choi Y, Min WS, Kim TG, Cho BS, Kim SY, Eom KS, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Kim CC. Kim HJ, et al. Among authors: min ws, min ck. Transplantation. 2007 Nov 15;84(9):1082-91. doi: 10.1097/01.tp.0000285918.72930.35. Transplantation. 2007. PMID: 17998861
Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.
Lee SE, Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Kim DW, Lee JW, Park CW, Kim CC. Lee SE, et al. Among authors: min ws, min ck. Int J Hematol. 2010 Sep;92(2):342-50. doi: 10.1007/s12185-010-0649-y. Epub 2010 Aug 10. Int J Hematol. 2010. PMID: 20694843 Clinical Trial.
253 results